Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley T Crooke

Showing results (61-70 of 122) with videos related to

Pageof 13
Sort By:
Plos One|July 30, 2014
Defining the factors that contribute to on-target specificity of antisense oligonucleotidesWalt F Lima, Timothy A Vickers, Josh Nichols, et al.
Nature Biotechnology|March 1, 2017
Cellular uptake and trafficking of antisense oligonucleotidesStanley T Crooke, Shiyu Wang, Timothy A Vickers, et al.
Nucleic Acids Research|May 28, 2014
TCP1 complex proteins interact with phosphorothioate oligonucleotides and can co-localize in oligonucleotide-induced nuclear bodies in mammalian cellsXue-hai Liang, Wen Shen, Hong Sun, et al.
Plos One|March 14, 2017
Depletion of NEAT1 lncRNA attenuates nucleolar stress by releasing sequestered P54nrb and PSF to facilitate c-Myc translationWen Shen, Xue-Hai Liang, Hong Sun, et al.
Plos One|October 22, 2014
Targeting of repeated sequences unique to a gene results in significant increases in antisense oligonucleotide potencyTimothy A Vickers, Susan M Freier, Huynh-Hoa Bui, et al.
The Journal of Biological Chemistry|February 13, 2004
Determination of the role of the human RNase H1 in the pharmacology of DNA-like antisense drugsHongjiang Wu, Walt F Lima, Hong Zhang, et al.
Nucleic Acids Research|June 6, 2019
mRNA levels can be reduced by antisense oligonucleotides via no-go decay pathwayXue-Hai Liang, Joshua G Nichols, Chih-Wei Hsu, et al.
Biochemical Pharmacology|August 18, 2020
Antisense drug discovery and development technology considered in a pharmacological contextStanley T Crooke, Xue-Hai Liang, Rosanne M Crooke, et al.
Nucleic Acid Therapeutics|February 3, 2021
Solid-Phase Separation of Toxic Phosphorothioate Antisense Oligonucleotide-Protein Nucleolar Aggregates Is CytoprotectiveXue-Hai Liang, Cheryl Li De Hoyos, Wen Shen, et al.
Nature Biotechnology|July 12, 2016
Translation efficiency of mRNAs is increased by antisense oligonucleotides targeting upstream open reading framesXue-Hai Liang, Wen Shen, Hong Sun, et al.
Pageof 13

Showing results (61-70 of 122) with videos related to

Sort By:
Pageof 13
Plos One|July 30, 2014
Defining the factors that contribute to on-target specificity of antisense oligonucleotidesWalt F Lima, Timothy A Vickers, Josh Nichols, et al.
Nature Biotechnology|March 1, 2017
Cellular uptake and trafficking of antisense oligonucleotidesStanley T Crooke, Shiyu Wang, Timothy A Vickers, et al.
Nucleic Acids Research|May 28, 2014
TCP1 complex proteins interact with phosphorothioate oligonucleotides and can co-localize in oligonucleotide-induced nuclear bodies in mammalian cellsXue-hai Liang, Wen Shen, Hong Sun, et al.
Plos One|March 14, 2017
Depletion of NEAT1 lncRNA attenuates nucleolar stress by releasing sequestered P54nrb and PSF to facilitate c-Myc translationWen Shen, Xue-Hai Liang, Hong Sun, et al.
Plos One|October 22, 2014
Targeting of repeated sequences unique to a gene results in significant increases in antisense oligonucleotide potencyTimothy A Vickers, Susan M Freier, Huynh-Hoa Bui, et al.
The Journal of Biological Chemistry|February 13, 2004
Determination of the role of the human RNase H1 in the pharmacology of DNA-like antisense drugsHongjiang Wu, Walt F Lima, Hong Zhang, et al.
Nucleic Acids Research|June 6, 2019
mRNA levels can be reduced by antisense oligonucleotides via no-go decay pathwayXue-Hai Liang, Joshua G Nichols, Chih-Wei Hsu, et al.
Biochemical Pharmacology|August 18, 2020
Antisense drug discovery and development technology considered in a pharmacological contextStanley T Crooke, Xue-Hai Liang, Rosanne M Crooke, et al.
Nucleic Acid Therapeutics|February 3, 2021
Solid-Phase Separation of Toxic Phosphorothioate Antisense Oligonucleotide-Protein Nucleolar Aggregates Is CytoprotectiveXue-Hai Liang, Cheryl Li De Hoyos, Wen Shen, et al.
Nature Biotechnology|July 12, 2016
Translation efficiency of mRNAs is increased by antisense oligonucleotides targeting upstream open reading framesXue-Hai Liang, Wen Shen, Hong Sun, et al.
Pageof 13